Avram Goldstein - Publications

Affiliations: 
Stanford University, Palo Alto, CA 
Area:
opioid pharmacology

129 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 Quertemont E, Grant KA, Correa M, Arizzi MN, Salamone JD, Tambour S, Aragon CM, McBride WJ, Rodd ZA, Goldstein A, Zaffaroni A, Li TK, Pisano M, Diana M. The role of acetaldehyde in the central effects of ethanol. Alcoholism, Clinical and Experimental Research. 29: 221-34. PMID 15714045 DOI: 10.1097/01.Alc.0000156185.39073.D2  1
2005 Rodd ZA, Bell RL, Zhang Y, Murphy JM, Goldstein A, Zaffaroni A, Li TK, McBride WJ. Regional heterogeneity for the intracranial self-administration of ethanol and acetaldehyde within the ventral tegmental area of alcohol-preferring (P) rats: involvement of dopamine and serotonin. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 330-8. PMID 15383830 DOI: 10.1038/Sj.Npp.1300561  1
2003 Goldstein A, Brown BW. Urine testing in methadone maintenance treatment: applications and limitations. Journal of Substance Abuse Treatment. 25: 61-3. PMID 14629984 DOI: 10.1016/S0740-5472(03)00066-7  1
2003 Rodd ZA, Bell RL, Zhang Y, Goldstein A, Zaffaroni A, McBride WJ, Li TK. Salsolinol produces reinforcing effects in the nucleus accumbens shell of alcohol-preferring (P) rats. Alcoholism, Clinical and Experimental Research. 27: 440-9. PMID 12658109 DOI: 10.1097/01.Alc.0000056612.89957.B4  1
2002 Naranda T, Kaufman RI, Li J, Wong K, Boge A, Hallén D, Fung KY, Duncan MW, Andersen N, Goldstein A, Olsson L. Activation of erythropoietin receptor through a novel extracellular binding site. Endocrinology. 143: 2293-302. PMID 12021194 DOI: 10.1210/Endo.143.6.8860  1
2002 Rodd-Henricks ZA, Melendez RI, Zaffaroni A, Goldstein A, McBride WJ, Li TK. The reinforcing effects of acetaldehyde in the posterior ventral tegmental area of alcohol-preferring rats. Pharmacology, Biochemistry, and Behavior. 72: 55-64. PMID 11900769 DOI: 10.1016/S0091-3057(01)00733-X  1
1999 Naranda T, Wong K, Kaufman RI, Goldstein A, Olsson L. Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site Proceedings of the National Academy of Sciences of the United States of America. 96: 7569-7574. PMID 10377456 DOI: 10.1073/pnas.96.13.7569  1
1997 Naranda T, Goldstein A, Olsson L. A peptide derived from an extracellular domain selectively inhibits receptor internalization: Target sequences on insulin and insulin-like growth factor 1 receptors Proceedings of the National Academy of Sciences of the United States of America. 94: 11692-11697. PMID 9326672 DOI: 10.1073/pnas.94.21.11692  1
1997 Goldstein A. A rewarding research pathway Annual Review of Pharmacology and Toxicology. 37: 1-28. PMID 9131244 DOI: 10.1146/Annurev.Pharmtox.37.1.1  1
1995 Goldstein A, Herrera J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up Drug and Alcohol Dependence. 40: 139-150. PMID 8745136 DOI: 10.1016/0376-8716(95)01205-2  1
1994 Xie GX, Meng F, Mansour A, Thompson RC, Hoversten MT, Goldstein A, Watson SJ, Akil H. Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor. Proceedings of the National Academy of Sciences of the United States of America. 91: 3779-83. PMID 8170987 DOI: 10.1073/Pnas.91.9.3779  1
1994 Olsson L, Goldstein A, Stagsted J. Regulation of receptor internalization by the major histocompatibility complex class I molecule Proceedings of the National Academy of Sciences of the United States of America. 91: 9086-9090. PMID 8090774 DOI: 10.1073/pnas.91.19.9086  1
1993 Stagsted J, Mapelli C, Meyers C, Matthews BW, Anfinsen CB, Goldstein A, Olsson L. Amino acid residues essential for biological activity of a peptide derived from a major histocompatibility complex class I antigen. Proceedings of the National Academy of Sciences of the United States of America. 90: 7686-90. PMID 8356070 DOI: 10.1073/Pnas.90.16.7686  1
1993 Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proceedings of the National Academy of Sciences of the United States of America. 90: 9954-8. PMID 8234341 DOI: 10.1073/Pnas.90.21.9954  1
1992 Xie GX, Miyajima A, Goldstein A. Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands Proceedings of the National Academy of Sciences of the United States of America. 89: 4124-4128. PMID 1315051 DOI: 10.1073/Pnas.89.9.4124  1
1991 Goldstein A. Heroin addiction: Neurobiology, pharmacology, and policy† Journal of Psychoactive Drugs. 23: 123-133. PMID 1662715 DOI: 10.1080/02791072.1991.10472231  1
1990 Goldstein A, Kalant H. Drug policy: striking the right balance. Science (New York, N.Y.). 249: 1513-21. PMID 2218493 DOI: 10.1126/Science.2218493  1
1990 Stagsted J, Reaven GM, Hansen T, Goldstein A, Olsson L. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen Cell. 62: 297-307. PMID 2196997 DOI: 10.1016/0092-8674(90)90367-N  1
1990 Xie GX, Miyajima A, Yokota T, Arai KI, Goldstein A. Chimeric opioid peptides: Tools for identifying opioid receptor types Proceedings of the National Academy of Sciences of the United States of America. 87: 3180-3184. PMID 2158105 DOI: 10.1073/Pnas.87.8.3180  1
1990 Goldstein A, Naidu A. Dextrorphan binds to opioid receptors in guinea-pig brain membranes and is an antagonist at opioid receptors in myenteric plexus Proceedings of the National Academy of Sciences of the United States of America. 87: 1629-1632. PMID 2155421 DOI: 10.1073/Pnas.87.5.1629  1
1989 Hansen T, Stagsted J, Pedersen L, Roth RA, Goldstein A, Olsson L. Inhibition of insulin receptor phosphorylation by peptides derived from major histocompatibility complex class I antigens Proceedings of the National Academy of Sciences of the United States of America. 86: 3123-3126. PMID 2566166 DOI: 10.1073/Pnas.86.9.3123  1
1989 Goldstein A, Brutlag DL. Is there a relationship between DNA sequences encoding peptide ligands and their receptors? Proceedings of the National Academy of Sciences of the United States of America. 86: 42-5. PMID 2536158 DOI: 10.1073/Pnas.86.1.42  1
1988 Weitz CJ, Lowney LI, Faull KF, Feistner G, Goldstein A. 6-Acetylmorphine: a natural product present in mammalian brain. Proceedings of the National Academy of Sciences of the United States of America. 85: 5335-8. PMID 3393541 DOI: 10.1073/Pnas.85.14.5335  1
1988 Goldstein A, Nestor JJ, Naidu A, Newman SR. 'DAKLI': A multipurpose ligand with high affinity and selectivity for dynorphin (κ opioid) binding sites Proceedings of the National Academy of Sciences of the United States of America. 85: 7375-7379. PMID 2902630 DOI: 10.1073/Pnas.85.19.7375  1
1988 Sibinga NES, Goldstein A. Opioid peptides and opioid receptors in cells of the immune system Annual Review of Immunology. 6: 219-249. PMID 2838048 DOI: 10.1146/ANNUREV.IY.06.040188.001251  1
1987 Weitz CJ, Faull KF, Goldstein A. Synthesis of the skeleton of the morphine molecule by mammalian liver. Nature. 330: 674-7. PMID 3683586 DOI: 10.1038/330674A0  1
1987 Goldstein A. Criteria of a Pharmacologic Withdrawal Syndrome Archives of General Psychiatry. 44: 392. PMID 3566460 DOI: 10.1001/archpsyc.1987.01800160108016  1
1987 Goldstein A. Binding selectivity profiles for ligands of multiple receptor types: Focus on opioid receptors Trends in Pharmacological Sciences. 8: 456-459. DOI: 10.1016/0165-6147(87)90038-1  1
1986 Goldstein A. The Sidney Cohen lectureship in drug abuse medicine Journal of Substance Abuse Treatment. 3: 157-161. PMID 3806728 DOI: 10.1016/0740-5472(86)90016-4  1
1986 Barrett RW, James IF, Goldstein A. Comparative immuno-removal: A novel method for estimating the concentration of an unknown immunoreactive compound Biochemical and Biophysical Research Communications. 137: 316-322. PMID 3521606 DOI: 10.1016/0006-291X(86)91212-X  1
1986 Weitz CJ, Lowney LI, Faull KF, Feistner G, Goldstein A. Morphine and codeine from mammalian brain. Proceedings of the National Academy of Sciences of the United States of America. 83: 9784-8. PMID 3467337 DOI: 10.1073/Pnas.83.24.9784  1
1986 Devi L, Goldstein A. Opioid and other peptides as inhibitors of leumorphin (dynorphin B-29) converting activity Peptides. 7: 87-90. PMID 3012492 DOI: 10.1016/0196-9781(86)90066-5  1
1986 Devi L, Goldstein A. Conversion of leumorphin (dynorphin B-29) to dynorphin B and dynorphin B-14 by thiol protease activity Journal of Neurochemistry. 47: 154-157. PMID 2872272 DOI: 10.1111/J.1471-4159.1986.Tb02843.X  1
1985 Goldstein A, Barrett RW, James IF, Lowney LI, Weitz CJ, Knipmeyer LL, Rapoport H. Morphine and other opiates from beef brain and adrenal. Proceedings of the National Academy of Sciences of the United States of America. 82: 5203-7. PMID 3860854 DOI: 10.1073/pnas.82.15.5203  1
1985 Civelli O, Douglass J, Goldstein A, Herbert E. Sequence and expression of the rat prodynorphin gene. Proceedings of the National Academy of Sciences of the United States of America. 82: 4291-5. PMID 3858883 DOI: 10.1073/Pnas.82.12.4291  1
1985 Devi L, Goldstein A. Neuropeptide processing by single-step cleavage: Conversion of leumorphin (dynorphin B-29) to dynorphin B Biochemical and Biophysical Research Communications. 130: 1168-1176. PMID 2862869 DOI: 10.1016/0006-291X(85)91738-3  1
1985 Barrett RW, Goldstein A. A monoclonal antibody specific for a dynorphin precursor Neuropeptides. 6: 113-120. PMID 2860615 DOI: 10.1016/0143-4179(85)90102-7  1
1984 Cox BM, Goldstein A, Nelson WT. Nicotine self-administration in rats. British Journal of Pharmacology. 83: 49-55. PMID 6487896 DOI: 10.1111/J.1476-5381.1984.Tb10118.X  1
1984 Judson BA, Goldstein A. Naltrexone treatment of heroin addiction: One-year follow-up Drug and Alcohol Dependence. 13: 357-365. PMID 6479015 DOI: 10.1016/0376-8716(84)90003-6  1
1984 Han JS, Xie GX, Goldstein A. Analgesia induced by intrathecal injection of dynorphin B in the rat Life Sciences. 34: 1573-1579. PMID 6371415 DOI: 10.1016/0024-3205(84)90612-X  1
1984 Devi L, Goldstein A. Dynorphin converting enzyme with unusual specificity from rat brain Proceedings of the National Academy of Sciences of the United States of America. 81: 1892-1896. PMID 6143321 DOI: 10.1073/Pnas.81.6.1892  1
1984 Chavkin C, Goldstein A. Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus. Proceedings of the National Academy of Sciences of the United States of America. 81: 7253-7. PMID 6095280 DOI: 10.1073/Pnas.81.22.7253  1
1984 Goldstein A, James IF. Multiple opioid receptors criteria for identification and classification Trends in Pharmacological Sciences. 5: 503-505. DOI: 10.1016/0165-6147(84)90527-3  1
1983 Judson BA, Goldstein A. Episodes of heroin use during maintenance treatment with stable dosage of (-)-α-acetylmethadol (methadyl acetate, LAAM) Drug and Alcohol Dependence. 11: 271-278. PMID 6617466 DOI: 10.1016/0376-8716(83)90018-2  1
1983 Judson BA, Goldstein A, Inturrisi CE. Methadyl Acetate (LAAM) in the Treatment of Heroin Addicts: II. Double-blind Comparison of Gradual and Abrupt Detoxification Archives of General Psychiatry. 40: 834-840. PMID 6347117 DOI: 10.1001/Archpsyc.1983.01790070024003  1
1983 Grevert P, Albert LH, Goldstein A. Partial antagonism of placebo analgesia by naloxone Pain. 16: 129-143. PMID 6308540 DOI: 10.1016/0304-3959(83)90203-8  1
1983 Goldstein A. Some thoughts about endogenous opioids and addiction Drug and Alcohol Dependence. 11: 11-14. PMID 6303738 DOI: 10.1016/0376-8716(83)90088-1  1
1983 Cone RI, Weber E, Barchas JD, Goldstein A. Regional distribution of dynorphin and neo-endorphin peptides in rat brain, spinal cord, and pituitary. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 3: 2146-52. PMID 6138396 DOI: 10.1523/Jneurosci.03-11-02146.1983  1
1983 McGinty JF, Henriksen SJ, Goldstein A, Terenius L, Bloom FE. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 80: 589-93. PMID 6132379 DOI: 10.1073/pnas.80.2.589  1
1983 Watson SJ, Khachaturian H, Taylor L, Fischli W, Goldstein A, Akil H. Pro-dynorphin peptides are found in the same neurons throughout rat brain: immunocytochemical study. Proceedings of the National Academy of Sciences of the United States of America. 80: 891-4. PMID 6131416 DOI: 10.1073/Pnas.80.3.891  1
1983 Spampinato S, Goldstein A. Immunoreactive dynorphin in rat tissues and plasma Neuropeptides. 3: 193-212. DOI: 10.1016/0143-4179(83)90016-1  1
1982 Judson BA, Goldstein A. Prediction of long-term outcome for heroin addicts admitted to a methadone maintenance program Drug and Alcohol Dependence. 10: 383-391. PMID 7166147 DOI: 10.1016/0376-8716(82)90040-0  1
1982 Judson BA, Goldstein A. Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers Drug and Alcohol Dependence. 10: 269-282. PMID 7166139 DOI: 10.1016/0376-8716(82)90021-7  1
1982 Cone RI, Goldstein A. A specific radioimmunoassay for the opioid peptide dynorphin B in neural tissues Neuropeptides. 3: 97-106. PMID 7162565 DOI: 10.1016/0143-4179(82)90005-1  1
1982 McGinty JF, Henriksen SJ, Goldstein A, Terenius L, Bloom FE. Opioid peptide identity and localization in hippocampus. Life Sciences. 31: 1797-800. PMID 6759828 DOI: 10.1016/0024-3205(82)90213-2  1
1982 Chavkin C, Goldstein A. Reduction in opiate receptor reserve in morphine tolerant guinea pig ilea. Life Sciences. 31: 1687-90. PMID 6296572 DOI: 10.1016/0024-3205(82)90186-2  1
1982 Khachaturian H, Watson SJ, Lewis ME, Coy D, Goldstein A, Akil H. Dynorphin immunocytochemistry in the rat central nervous system. Peptides. 3: 941-54. PMID 6132365 DOI: 10.1016/0196-9781(82)90063-8  1
1982 Goldstein A. "Immunoreactive dynorphin" in escherichia coli: Tracer degradation by a heat-stable endopeptidase Life Sciences. 31: 2267-2270. PMID 6131358 DOI: 10.1016/0024-3205(82)90134-5  1
1982 James IF, Chavkin C, Goldstein A. Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin. Proceedings of the National Academy of Sciences of the United States of America. 79: 7570-4. PMID 6130527 DOI: 10.1073/Pnas.79.23.7570  1
1982 Fischli W, Goldstein A, Hunkapiller MW, Hood LE. Two "big" dynorphins from porcine pituitary Life Sciences. 31: 1769-1772. PMID 6130436 DOI: 10.1016/0024-3205(82)90206-5  1
1982 Watson SJ, Khachaturian H, Akil H, Coy DH, Goldstein A. Comparison of the distribution of dynorphin systems and enkephalin systems in brain. Science (New York, N.Y.). 218: 1134-6. PMID 6128790 DOI: 10.1126/Science.6128790  1
1982 Sweetnam PM, Neale JH, Barker JL, Goldstein A. Localization of immunoreactive dynorphin in neurons cultured from spinal cord and dorsal root ganglia. Proceedings of the National Academy of Sciences of the United States of America. 79: 6742-6. PMID 6128736  1
1982 James IF, Chavkin C, Goldstein A. Selectivity of dynorphin for kappa opioid receptors. Life Sciences. 31: 1331-4. PMID 6128656 DOI: 10.1016/0024-3205(82)90374-5  1
1982 Fischli W, Goldstein A, Hunkapiller MW, Hood LE. Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary Proceedings of the National Academy of Sciences of the United States of America. 79: 5435-5437. PMID 6127674 DOI: 10.1073/Pnas.79.17.5435  1
1982 Cone RI, Goldstein A. A dynorphin-like opioid in the central nervous system of an amphibian Proceedings of the National Academy of Sciences of the United States of America. 79: 3345-3349. PMID 6124969 DOI: 10.1073/Pnas.79.10.3345  1
1982 Watson SJ, Akil H, Fischli W, Goldstein A, Zimmerman E, Nilaver G, Van Wimersma Greidanus TB. Dynorphin and vasopressin: Common localization in magnocellular neurons Science. 216: 85-87. PMID 6121376 DOI: 10.1126/SCIENCE.6121376  1
1982 Chavkin C, James IF, Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science (New York, N.Y.). 215: 413-5. PMID 6120570 DOI: 10.1126/Science.6120570  1
1982 Leslie FM, Goldstein A. Degradation of dynorphin-(1-13) by membrane-bound rat brain enzymes Neuropeptides. 2: 185-196. DOI: 10.1016/0143-4179(82)90051-8  1
1981 Judson BA, Carney TM, Goldstein A. Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison. Drug and Alcohol Dependence. 7: 325-46. PMID 7023894 DOI: 10.1016/0376-8716(81)90049-1  1
1981 Romano C, Goldstein A, Jewell NP. Characterization of the receptor mediating the nicotine discriminative stimulus Psychopharmacology. 74: 310-315. PMID 6794072 DOI: 10.1007/BF00432737  1
1981 Chavkin C, Goldstein A. Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus. Nature. 291: 591-3. PMID 6264311 DOI: 10.1038/291591a0  1
1981 Dent RR, Guilleminault C, Albert LH, Posner BI, Cox BM, Goldstein A. Diurnal rhythm of plasma immunoreactive beta-endorphin and its relationship to sleep stages and plasma rhythms of cortisol and prolactin. The Journal of Clinical Endocrinology and Metabolism. 52: 942-7. PMID 6262357 DOI: 10.1210/Jcem-52-5-942  1
1981 Botticelli LJ, Cox BM, Goldstein A. Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia. Proceedings of the National Academy of Sciences of the United States of America. 78: 7783-6. PMID 6121324  1
1981 Goldstein A, Fischli W, Lowney LI, Hunkapiller M, Hood L. Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide Proceedings of the National Academy of Sciences of the United States of America. 78: 7219-7223. PMID 6118870 DOI: 10.1073/Pnas.78.11.7219  1
1981 Chavkin C, Goldstein A. Specific receptor for the opioid peptide dynorphin: structure--activity relationships. Proceedings of the National Academy of Sciences of the United States of America. 78: 6543-7. PMID 6118865 DOI: 10.1073/Pnas.78.10.6543  1
1981 Watson SJ, Akil H, Ghazarossian VE, Goldstein A. Dynorphin immunocytochemical localization in brain and peripheral nervous system: Preliminary studies Proceedings of the National Academy of Sciences of the United States of America. 78: 1260-1263. PMID 6112743 DOI: 10.1073/PNAS.78.2.1260  1
1981 Herman BH, Goldstein A. Cataleptic effects of dynorphin-(1-13) in rats made tolerant to a mu opiate receptor agonist Neuropeptides. 2: 13-22. DOI: 10.1016/0143-4179(81)90047-0  1
1980 Romano C, Goldstein A. Stereospecific nicotine receptors on rat brain membranes Science. 210: 647-650. PMID 7433991 DOI: 10.1126/Science.7433991  1
1980 Herman BH, Leslie F, Goldstein A. Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in rats Life Sciences. 27: 883-892. PMID 7191035 DOI: 10.1016/0024-3205(80)90084-3  1
1980 Cox BM, Ghazarossian VE, Goldstein A. Levels of immunoreactive dynorphin in brain and pituitary of Brattleboro rats. Neuroscience Letters. 20: 85-8. PMID 6133255 DOI: 10.1016/0304-3940(80)90238-4  1
1980 Goldstein A, Ghazarossian VE. Immunoreactive dynorphin in pituitary and brain. Proceedings of the National Academy of Sciences of the United States of America. 77: 6207-6210. PMID 6108564 DOI: 10.1073/Pnas.77.10.6207  0.6
1980 Ghazarossian VE, Chavkin C, Goldstein A. A specific radioimmunoassay for the novel opioid peptide dynorphin. Life Sciences. 27: 75-86. PMID 6105608 DOI: 10.1016/0024-3205(80)90021-1  1
1980 Goldstein A. Thrills in response to music and other stimuli Physiological Psychology. 8: 126-129. DOI: 10.3758/BF03326460  1
1980 Ho WKK, Cox BM, Chavkin C, Goldstein A. Opioid peptide dynorphin-(1–13): Adsorptive losses and potency estimates Neuropeptides. 1: 143-152. DOI: 10.1016/0143-4179(80)90017-7  1
1980 Ho WKK, Cox BM, Chavkin C, Goldstein A. Opioid peptide dynorphin-(1-13): Adsorptive losses and potency estimates Neuropeptides. 1: 143-152.  1
1979 Baizman ER, Cox BM, Osman OH, Goldstein A. Experimental alterations of endorphin levels in rat pituitary. Neuroendocrinology. 28: 402-14. PMID 572491  1
1979 Ross M, Berger PA, Goldstein A. Plasma β-endorphin immunoreactivity in schizophrenia Science. 205: 1163-1164. PMID 472735 DOI: 10.1126/Science.472735  1
1979 Goldstein A, Tachibana S, Lowney LI, Hunkapiller M, Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide Proceedings of the National Academy of Sciences of the United States of America. 76: 6666-6670. PMID 230519 DOI: 10.1073/Pnas.76.12.6666  0.48
1979 Lowney LI, Gentleman SB, Goldstein A. A pituitary endorphin with novel properties Life Sciences. 24: 2377-2384. PMID 225623 DOI: 10.1016/0024-3205(79)90536-8  0.48
1979 Cox BM, Ross M, Goldstein A, Palmour RM. Pharmacological and immunological characterization of the Leu5 analogue of human beta-endorphin. Brain Research. 165: 311-9. PMID 217494 DOI: 10.1016/0006-8993(79)90562-6  1
1978 Grevert P, Baizman ER, Goldstein A. Naloxone effects on a nociceptive response of hypophysectomized and adrenalectomized mice. Life Sciences. 23: 723-728. PMID 692290 DOI: 10.1016/0024-3205(78)90072-3  0.44
1978 Gentleman S, Lowney LI, Cox BM, Goldstein A. Rapid purification of beta-endorphin by high-performance liquid chromatography. Journal of Chromatography. 153: 274-8. PMID 659560 DOI: 10.1016/S0021-9673(00)89885-4  1
1978 Ross M, Ghazarossian V, Cox BM, Goldstein A. Radioimmunoassays for beta-endorphin: comparison of properties of two antisera. Life Sciences. 22: 1123-30. PMID 566365 DOI: 10.1016/0024-3205(78)90081-4  1
1978 Goldstein A. Endorphins: physiology and clinical implications Annals of the New York Academy of Sciences. 311: 49-58. PMID 217294 DOI: 10.1002/j.2326-1951.1978.tb01642.x  0.01
1977 Goldstein A, Cox BM. Opioid peptides (endorphins) in pituitary and brain. Psychoneuroendocrinology. 2: 11-6. PMID 905473 DOI: 10.1016/0306-4530(77)90027-0  1
1977 Ross M, Dingledine R, Cox BM, Goldstein A. Distribution of endorphins (peptides with morphine-like pharmacological activity) in pituitary. Brain Research. 124: 523-32. PMID 851863 DOI: 10.1016/0006-8993(77)90951-9  1
1977 Cheung AL, Stavinoha WB, Goldstein A. Endorphins in brains of decapitated and microwave-killed mice Life Sciences. 20: 1285-1289. PMID 850478 DOI: 10.1016/0024-3205(77)90504-5  1
1977 Goldstein A, Cox BM, Klee WA, Nirenberg M. Endorphin from pituitary inhibits cyclic AMP formation in homogenates of neuroblastoma X glioma hybrid cells. Nature. 265: 362-3. PMID 189215 DOI: 10.1038/265362A0  1
1976 Goldstein A, Pryor GT, Otis LS, Larsen F. On the role of endogenous opioid peptides: Failure of naloxone to influence shock escape threshold in the rat Life Sciences. 18: 599-604. PMID 1263743 DOI: 10.1016/0024-3205(76)90339-8  1
1976 Goldstein A. Heroin Addiction: Sequential Treatment Employing Pharmacologic Supports Archives of General Psychiatry. 33: 353-358. PMID 1259524 DOI: 10.1001/archpsyc.1976.01770030061009  1
1976 Cox BM, Goldstein A, Hi CH. Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin. Proceedings of the National Academy of Sciences of the United States of America. 73: 1821-3. PMID 1064855  1
1976 Goldstein A. Opioid peptides (endorphins) in pituitary and brain. Studies on opiate receptors have led to identification of endogenous peptides with morphine like actions Science. 193: 1081-1086. PMID 959823 DOI: 10.1126/Science.959823  1
1976 Cheung AL, Goldstein A. Failure of hypophysectomy to alter brain content of opioid peptides (endorphins) Life Sciences. 19: 1005-1008. PMID 186675 DOI: 10.1016/0024-3205(76)90291-5  1
1976 Cox BM, Gentleman S, Su TP, Goldstein A. Further characterization of morphine-like peptides (endorphins) from pituitary. Brain Research. 115: 285-96. PMID 10049 DOI: 10.1016/0006-8993(76)90513-8  1
1975 Goldstein A. On the role off chemotherapy in the treatment of heroin addiction American Journal of Drug and Alcohol Abuse. 2: 279-288. PMID 1227291 DOI: 10.3109/00952997509005653  1
1975 Goldstein A, Goldstein JS, Cox BM. A synthetic peptide with morphine-like pharmacologic action. Life Sciences. 17: 1643-54. PMID 1207378 DOI: 10.1016/0024-3205(75)90109-5  1
1975 Teschemacher H, Opheim KE, Cox BM, Goldstein A. A peptide-like substance from pituitary that acts like morphine. I. Isolation. Life Sciences. 16: 1771-5. PMID 1171343  1
1975 Cox BM, Opheim KE, Teschemacher H, Goldstein A. A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties. Life Sciences. 16: 1777-82. PMID 1152601 DOI: 10.1016/0024-3205(75)90272-6  1
1975 Dingledine R, Goldstein A. Single neuron studies of opiate action in the guinea pig myenteric plexus. Life Sciences. 17: 57-62. PMID 1143011 DOI: 10.1016/0024-3205(75)90235-0  1
1975 Goldstein A, Hilgard ER. Failure of the opiate antagonist naloxone to modify hypnotic analgesia. Proceedings of the National Academy of Sciences of the United States of America. 72: 2041-3. PMID 1056010  1
1974 Dingledine R, Goldstein A, Kendig J. Effects of narcotic opiates and serotonin on the electrical behavior of neurons in the guinea pig myenteric plexus. Life Sciences. 14: 2299-309. PMID 4847817 DOI: 10.1016/0024-3205(74)90111-8  1
1974 Lowney LI, Schulz K, Lowery PJ, Goldstein A. Partial Purification of an Opiate Receptor from Mouse Brain Science. 183: 749-753. PMID 4821242 DOI: 10.1126/Science.183.4126.749  0.48
1973 Dingledine R, Goldstein A. Lethality of the morphinan isomers levorphanol and dextrorphan. British Journal of Pharmacology. 48: 718-20. PMID 4788214 DOI: 10.1111/j.1476-5381.1973.tb08261.x  1
1973 Goldstein A. Comments on the "isolation, identification and synthesis of a specific-behaviour-inducing brain peptide" Nature. 242: 60-62. PMID 4735102 DOI: 10.1038/242060a0  1
1972 Goldstein A. Heroin Addiction and the Role of Methadone in Its Treatment Archives of General Psychiatry. 26: 291-297. PMID 4622401 DOI: 10.1001/archpsyc.1972.01750220001001  1
1972 Goldstein A. Blind comparison of once-daily and twice-daily dosage schedules in a methadone program Clinical Pharmacology and Therapeutics. 13: 59-63. PMID 4550323 DOI: 10.1002/Cpt197213159  1
1971 Goldstein A, Lowney LI, Pal BK. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proceedings of the National Academy of Sciences of the United States of America. 68: 1742-7. PMID 5288759 DOI: 10.1073/pnas.68.8.1742  1
1971 Cheney DL, Goldstein A. Tolerance to opioid narcotics: time course and reversibility of physical dependence in mice. Nature. 232: 477-8. PMID 4937208 DOI: 10.1038/232477a0  1
1971 Goldstein A. Blind dosage comparisons and other studies in a large methadone program Journal of Psychoactive Drugs. 4: 177-181. DOI: 10.1080/02791072.1971.10471806  1
1968 Das HK, Goldstein A. Limited capacity for protein synthesis at zero degrees centigrade in Escherichia coli Journal of Molecular Biology. 31: 209-226. PMID 4865483 DOI: 10.1016/0022-2836(68)90440-3  1
1967 Das HK, Goldstein A, Lowney LI. Attachment of ribosomes to nascent messenger RNA in Escherichia coli. Journal of Molecular Biology. 24: 231-245. PMID 5339872 DOI: 10.1016/0022-2836(67)90329-4  0.48
1964 Goldstein A. Wakefulness caused by caffeine Naunyn-Schmiedebergs Archiv FüR Experimentelle Pathologie Und Pharmakologie. 248: 269-278. PMID 14230240 DOI: 10.1007/BF00348597  1
1964 Goldstein A, Goldstein DB, Lowney LI. Protein synthesis at 0°C in Escherichia coli Journal of Molecular Biology. 9: 213-235. PMID 14200385 DOI: 10.1016/S0022-2836(64)80102-9  0.48
1962 GOLDSTEIN A. Chain growth of proteins: some consequences for the coding problem Journal of Molecular Biology. 4: 121-122. PMID 13899874 DOI: 10.1016/S0022-2836(62)80045-X  1
1952 Goldstein A. Effect of penicillin on streptomycin-dependent variants in Escherichia coli populations Science. 116: 113. PMID 14950199 DOI: 10.1126/Science.116.3005.113  1
1951 Goldstein A. Properties and behavior of purified human plasma cholinesterase. III. Competitive inhibition by prostigmine and other alkaloids with special reference to differences in kinetic behavior Archives of Biochemistry and Biophysics. 34: 169-188. PMID 14904048 DOI: 10.1016/S0003-9861(51)80023-7  1
1951 GOLDSTEIN A, DOHERTY ME. Properties and behavior of purified human plasma cholinesterase. II. Inactivation by mercuric chloride. Archives of Biochemistry and Biophysics. 33: 35-49. PMID 14857773 DOI: 10.1016/0003-9861(51)90080-X  1
1951 GOLDSTEIN A, DOHERTY ME. Properties and behavior of purified human plasma cholinesterase. I. Stability and thermal denaturation. Archives of Biochemistry and Biophysics. 33: 22-34. PMID 14857772 DOI: 10.1016/0003-9861(51)90079-3  1
1949 Goldstein A. A "Free Manometer" Method of Using the Standard Warburg Apparatus Science (New York, N.Y.). 110: 400. PMID 17844562 DOI: 10.1126/Science.110.2859.400  1
Show low-probability matches.